share_log

Analyzing Asure Software (NASDAQ:ASUR) and Arbe Robotics (NASDAQ:ARBE)

Defense World ·  Jan 28, 2023 01:54

Arbe Robotics (NASDAQ:ARBE – Get Rating) and Asure Software (NASDAQ:ASUR – Get Rating) are both small-cap business services companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, dividends, profitability, earnings, analyst recommendations, valuation and institutional ownership.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for Arbe Robotics and Asure Software, as provided by MarketBeat.

Get Arbe Robotics alerts:
Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Arbe Robotics 0 0 1 0 3.00
Asure Software 1 0 0 0 1.00

Arbe Robotics presently has a consensus price target of $11.50, suggesting a potential upside of 205.04%. Asure Software has a consensus price target of $9.00, suggesting a potential downside of 10.00%. Given Arbe Robotics' stronger consensus rating and higher possible upside, equities analysts plainly believe Arbe Robotics is more favorable than Asure Software.

Volatility and Risk

Arbe Robotics has a beta of -0.18, indicating that its share price is 118% less volatile than the S&P 500. Comparatively, Asure Software has a beta of 0.75, indicating that its share price is 25% less volatile than the S&P 500.

Insider & Institutional Ownership

7.5% of Arbe Robotics shares are held by institutional investors. Comparatively, 61.7% of Asure Software shares are held by institutional investors. 53.5% of Arbe Robotics shares are held by insiders. Comparatively, 7.6% of Asure Software shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Profitability

This table compares Arbe Robotics and Asure Software's net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Arbe Robotics -1,163.30% -65.35% -52.06%
Asure Software -20.21% -0.89% -0.32%

Valuation and Earnings

This table compares Arbe Robotics and Asure Software's top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Arbe Robotics $2.25 million 105.80 -$58.09 million ($0.73) -5.16
Asure Software $76.06 million 2.65 $3.19 million ($0.88) -11.36

Asure Software has higher revenue and earnings than Arbe Robotics. Asure Software is trading at a lower price-to-earnings ratio than Arbe Robotics, indicating that it is currently the more affordable of the two stocks.

About Arbe Robotics

(Get Rating)

Arbe Robotics Ltd., a semiconductor company, provides 4D imaging radar solutions for tier 1 automotive suppliers and automotive manufacturers in Israel and the United States. It offers 4D imaging radar chipset solutions that address the core issues that have caused autonomous vehicle and autopilot accidents, such as detecting stationary objects, identifying vulnerable road users, and eliminating false alarms without radar ambiguities. The company was founded in 2015 and is headquartered in Tel Aviv-Yafo, Israel.

About Asure Software

(Get Rating)

Asure Software, Inc. delivers human capital management solutions through the lens of entrepreneurs and executives with an owner's mentality. It helps small and mid-sized businesses to develop their human capital and allocate their time, money and technology toward growth. Its solutions include Asure Payroll & Tax, Asure HR, and Asure Time & Attendance. The firm's Asure HRServices offer ranges from online compliance tools to a fully outsourced HR department. The company was founded in 1985 and is headquartered in Austin, TX.

Receive News & Ratings for Arbe Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arbe Robotics and related companies with MarketBeat.com's FREE daily email newsletter.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment